<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Phase II COVID-19 Clinical Study Successful in Israel
Image Overlay - Phase II COVID-19 Clinical Study Successful in Israel

Phase II COVID-19 Clinical Study Successful in Israel

Phase II COVID-19 Clinical Study Successful in Israel

Phase II results performed at two sites in Israel have demonstrated that ArtemiC, natural supplement and COVID-19 treatment, has met all primary endpoints and helps alleviate symptoms and hospitalization associated with the disease. Roby Zomer, co-founder and CEO of MGC Pharma, noted, “These results, combined with our recent preclinical results, are important for designing the protocols and markers for our next Phase IIb clinical trial.” Yourway has a 7,500 square foot local depot in Tel Aviv, Israel, to provide service to regions in the Middle East and Africa. Our clients are given access to 21 strategic depot locations around the globe, as well as the ability to seamlessly manage inventory through an easy-to-use client portal.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Pharma Supply Chain & Logistics Innovation Programme EU

May 20-21, 2026
Basel, Switzerland

Clinical Trial Supply West Coast

September 22-23, 2026
Burlingame, CA

Media

Articles

Global Reach in Clinical Trials: Beyond Presence to True Execution

Open chat
Come chat with us!
Hello! How can I help you?